
New AI tool forecasts diabetes complications in patients, helping prevent heart disease and kidney disease risks.

Stem cell donors are getting younger and better, with mismatched unrelated donors showing promising survival rates for adults…

FDA approves Rasonque, a first-in-class therapy for metastatic pancreatic cancer. Learn about this new targeted treatment.

Husband Kicked From Hospice for Dying Too Slowly: A story of unfair treatment and family struggle as a…

Margaret Murray critiques Republicans on Medicaid stance, calling the overhaul's provisions, including work requirements and redetermination cycles, deeply…

New AI tool forecasts diabetes complications in patients, helping prevent heart disease and kidney disease risks.

The FDA approved Lisraya (brepocitinib) for dermatomyositis, a rare skin condition causing inflammation and muscle weakness, offering targeted…

FDA approves Rasonque, a first-in-class therapy for metastatic pancreatic cancer. Learn about this new targeted treatment.

Most people considering facial rejuvenation describe the same vague feeling: something looks different, but they cannot say exactly…

Stem cell donors are getting younger and better, with mismatched unrelated donors showing promising survival rates for adults…

A new study reveals how sensitive caregiving in infancy may reduce ADHD risk linked to prenatal inflammation, offering…

Discover why dermatologists are shifting toward anti-inflammatory seborrheic dermatitis treatment to improve patient outcomes and reduce drug resistance.

The FDA approves Pasatru, a breakthrough drug for fibrodysplasia ossificans progressiva (FOP), a rare bone disease affecting 900…

Sparsentan access guidance for kidney disease patients with evidence-based coverage criteria and clinical judgment.